MAP1LC3A exhibited higher methylation in Tr, iTreg, CD8T, exhausted, cytotoxic, DC, and macrophages in KIRC, SKCM, and LUAD, and lower methylation in CD8-naive, NK, neutrophils, and Th17 cells in the same cancer types. This evidence concerns the gene CD8A and cancer.